Advertisement

Organisation › Details
EU (govt)
![]() |
Region | Brussels |
Country | Belgium | |
City | n. a. Brussels | |
Address record changed: 2011-11-27 | ||
Basic data | Employees | n. a. |
Record changed: 2024-12-17 |
Advertisement

More documents for EU (govt)
- [1] European Invesmtent Bank (EIB). (1/14/25). "Press Release: Germany – EIB Provides €35 Million to Formo to Expand Production of Cheese Alternatives Free from Animal Products"....
- [2] Pentixapharm Holding AG. (8/26/24). "Press Release: Pentixapharm AG Receives Orphan Drug Designation for its Radiodiagnostic Tracer PentixaFor in Marginal Zone Lymphoma by the European Medicines Agency". Berlin & Würzburg....
- [3] Protembis GmbH. (7/30/24). "Press Release: German Medtech Protembis Gets €20 million EIB Backing for Technology to Protect Brain during Heart Treatment". Luxembourg & Aachen....
- [4] Boehringer Ingelheim. (7/29/24). "Press Release: CHMP Adopts Positive Opinion Recommending Approval of New and Expanded Indications for Spevigo". Ingelheim & La Jolla, CA....
- [5] Nyxoah S.A.. (7/3/24). "Press Release: Nyxoah Has Signed a €37.5 Million Loan Facility Agreement with the European Investment Bank". Mont-Saint-Guibert....
- [6] Valneva S.E.. (7/1/24). "Press Release: Valneva Receives Marketing Authorization in Europe for the World’s First Chikungunya Vaccine, Ixchiq". Saint Herblain....
- [7] XGen Venture SGR S.p.A.. (5/23/24). "Press Release: XGen Venture Announces €160 Million First Life Science Fund". Milan....
- [8] CRISPR Therapeutics AG. (2/13/24). "Press Release: European Commission Approves First CRISPR/Cas9 Gene-Edited Therapy, Casgevy (exagamglogene autotemcel), for the Treatment of Sickle Cell Disease (SCD) and Transfusion-Dependent Beta Thalassemia (TDT)". Z...
- [9] SolasCure Ltd.. (11/3/23). "Press Release: SolasCure Awarded Prestigious European Innovation Council’s Accelerator Grant"....
- [10] Roche. (10/30/23). "Press Release: Roche Announces EMBARK Trial in Duchenne Muscular Dystrophy (DMD) Did Not Reach Primary Endpoint, but Shows Positive Efficacy Outcomes on All Timed Functional Key Endpoints". Basel....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement

» top